IGFBP1 and type 2 diabetes mellitus: The IGFBP-1 levels increased significantly in the T2D group after six months of intervention, which is possibly explained by reduced C-peptide/insulin secretion and improved hepatic insulin sensitivity due to reduced liver fat accumulation [28].